(2024). Effect of Local Dexamethasone on Prevention of Myringosclerosis after Tympanostomy Tube insertion. The Egyptian Journal of Hospital Medicine, 95(1), 1297-1301. doi: 10.21608/ejhm.2024.348396
. "Effect of Local Dexamethasone on Prevention of Myringosclerosis after Tympanostomy Tube insertion". The Egyptian Journal of Hospital Medicine, 95, 1, 2024, 1297-1301. doi: 10.21608/ejhm.2024.348396
(2024). 'Effect of Local Dexamethasone on Prevention of Myringosclerosis after Tympanostomy Tube insertion', The Egyptian Journal of Hospital Medicine, 95(1), pp. 1297-1301. doi: 10.21608/ejhm.2024.348396
Effect of Local Dexamethasone on Prevention of Myringosclerosis after Tympanostomy Tube insertion. The Egyptian Journal of Hospital Medicine, 2024; 95(1): 1297-1301. doi: 10.21608/ejhm.2024.348396
Effect of Local Dexamethasone on Prevention of Myringosclerosis after Tympanostomy Tube insertion
Background: Otitis media with effusion, a typical condition characterized by fluid in the middle ear area, has a significant negative influence on both the health and economy of the entire world. In children, hearing loss brought on by otitis media with effusion can hinder the development of language and conduct. This study aimed to assess how local dexamethasone affects human tympanic membranes' ability to resist myringosclerosis brought on by ventilation tubes. Patients and Methods: This prospective case-control study was conducted at Benha University Hospital, on 50 patients of both sexes and different ages complained of hearing loss due to persistent otitis media with effusion that has been resistant to therapy for nearly three months. The patients were subdivided into two equal groups: 25 patients were participants in group (A), which underwent myringotomy with breathing tube insertion only. 25 patients were participants in group (B), who had myringotomy, breathing tube insertion, and local dexamethasone instillation. Results: As far as myringosclerosis was concerned, there was no statistically significant variation between the two groups (P-value > 0.05). As determined by the quadrants under otomicroscopic examination, there was a significant variation between the two groups (P-value < 0.01) in relation to myringosclerosis findings. The histopathological assessment of myringosclerosis revealed a significant variation between the two groups with regard to the condition's symptoms (P-value < 0.01). Conclusion:Topical dexamethasone use may be helpful in avoiding the development of myringosclerosis. Dexamethasone's anti-inflammatory and immunosuppressive properties may be responsible for this impact.